Population screening for reproductive risk for single gene disorders in Australia: Now and the future

被引:14
作者
Delatycki, Martin B. [1 ]
机构
[1] Murdoch Childrens Res Inst, Bruce Lefroy Ctr Genet Hlth Res, Murdoch, WA, Australia
关键词
screening; carrier; cystic fibrosis; thalassaemia; Tay Sachs disease;
D O I
10.1375/twin.11.4.422
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
As the results of the Human Genome Project are realized, it has become technically possible to identify carriers of numerous autosomal and X-linked recessive disorders. Couples at risk of having a child with one of these conditions have a number of reproductive options to avoid having a child with the condition should they wish. In Australia the haemoglobinopathies are the only group of conditions for which population screening is widely offered and which is government funded. In some Australian states there are also population screening programs for cystic fibrosis and autosomal recessive conditions more common in Ashkenazi Jewish individuals which are generally offered on a user pays basis. It is predicted that as consumer demand increases and testing becomes cheaper, that many people planning or in the early stages of pregnancy will have carrier screening for multiple genetic conditions. This will have significant implications for genetic counseling, laboratory and prenatal testing resources. In addition such screening raises a number of ethical issues including the value of lives of those born with genetic conditions for which screening is available.
引用
收藏
页码:422 / 430
页数:9
相关论文
共 69 条
  • [1] Revisiting Wilson and Jungner in the genomic age:: a review of screening criteria over the past 40 years
    Andermann, Anne
    Blancquaert, Ingeborg
    Beauchamp, Sylvie
    Dery, Veronique
    [J]. BULLETIN OF THE WORLD HEALTH ORGANIZATION, 2008, 86 (04) : 317 - 319
  • [2] Global epidemiology of hemoglobin disorders
    Angastiniotis, M
    Modell, B
    [J]. COOLEYS ANEMIA: SEVENTH SYMPOSIUM, 1998, 850 : 251 - 269
  • [3] [Anonymous], OBSTET GYNECOL
  • [4] Population genetic screening programmes: technical, social and ethical issues
    Ayme, S
    [J]. EUROPEAN JOURNAL OF HUMAN GENETICS, 2003, 11 (12) : 903 - 905
  • [5] Bach G, 2001, AM J MED GENET, V99, P70, DOI 10.1002/1096-8628(20010215)99:1<70::AID-AJMG1120>3.0.CO
  • [6] 2-0
  • [7] A genetic screening programme for Tay-Sachs disease and cystic fibrosis for Australian Jewish high school students
    Barlow-Stewart, K
    Brunett, L
    Proos, A
    Howell, V
    Huq, F
    Lazarus, R
    Aizenberg, H
    [J]. JOURNAL OF MEDICAL GENETICS, 2003, 40 (04)
  • [8] Barlow-Stewart K, 2007, AUST FAM PHYSICIAN, V36, P802
  • [9] Preconceptional and prenatal screening for fragile X syndrome: Experience with 40 000 tests
    Berkenstadt, Michal
    Ries-Levavi, Liat
    Cuckle, Howard
    Peleg, Leah
    Barkai, Gad
    [J]. PRENATAL DIAGNOSIS, 2007, 27 (11) : 991 - 994
  • [10] BEUTLER E, 1971, NEW ENGL J MED, V285, P1485